The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gestational Diabetes Mother-infant Cohort

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06021691
Recruitment Status : Recruiting
First Posted : September 1, 2023
Last Update Posted : September 1, 2023
Sponsor:
Information provided by (Responsible Party):
Gansu Provincial Maternal and Child Health Care Hospital

Brief Summary:
The bi-directional dynamic cohort study is to learn about the effects of prenatal exposure to high blood glucose levels and postnatal nurturing environment factors on delayed language development in children. The study investigated the results of blood glucose screening during pregnancy for the children's mothers, and followed up on the blood glucose management effectiveness of pregnant women with abnormal blood glucose levels before delivery. Participants will be also surveyed the "S-S method for language development assessment, "gsell Scale", and "0-6 year-old family nurturing environment evaluation scale" to evaluate the language development and family nurturing environment.

Condition or disease Intervention/treatment
Gestational Diabetes Mellitus in Pregnancy Cognitive Impairment Cohort Study Behavioral: Acquired nurturing environment

Detailed Description:
Glucose management during pregnancy and the postnatal nurturing environment are keys to early detection and early intervention of language delay, which is important to reduce abnormal language development in children. In this study, mothers diagnosed with gestational diabetes mellitus in the department of hospital and offspring were used as participants. The investigators take a follow-up visit to participants' offspring using the S-S method of language development assessment, gsell Infant and Toddler Development Scale, and 0-6 years old family parenting environment evaluation scale. The bi-directional dynamic cohort study is to learn about the effects of prenatal exposure to high blood glucose levels and postnatal nurturing environment factors on delayed language development in children.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Cohort Study on the Impact of Gestational Blood Glucose Management and Postnatal Nurturing Environment on Delayed Language Development in Children
Actual Study Start Date : February 1, 2023
Estimated Primary Completion Date : November 30, 2025
Estimated Study Completion Date : November 30, 2025

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Gestational diabetes offspring cohort
The Gestational diabetes(GDM) offspring cohort is to learn about language development assessment in 2-year-old children and causal association with their mother who diagnosed GDM
Behavioral: Acquired nurturing environment
Superimposed effects of intrauterine high-sugar environment exposure and postnatal nurturing environment exposure

Healthy maternal offspring cohort
Healthy maternal offspring cohort is to learn about language development assessment in 2-year-old children and causal association with their health mother
Behavioral: Acquired nurturing environment
Superimposed effects of intrauterine high-sugar environment exposure and postnatal nurturing environment exposure




Primary Outcome Measures :
  1. delayed language development in children [ Time Frame: 2023.1-2025.11 ]
    "Number of participants diagnosed with GDM," "Number of offspring of participants who participated in the survey of family nurturing environments," and "Composition ratio of offspring with GDM who presented with language delays."


Biospecimen Retention:   Samples With DNA
Collection of maternal peripheral blood during pregnancy and umbilical cord blood at delivery


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   1 Year to 3 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The pregnant women with abnormal blood glucose levels and the offspring
Criteria

Inclusion Criteria:

  • Children 1.5-2.5 years old with no serious underlying diseases and no hearing impairment.

Exclusion Criteria:

  • diagnosed hearing impairment, organic dysarthria, oral disease; (ii) cerebral palsy;
  • neurological and hereditary metabolic diseases; (iv) deaf father/mother.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06021691


Contacts
Layout table for location contacts
Contact: Yanxia Wang, Dr. 86-0931-5188689 1091771450@qq.com

Locations
Layout table for location information
China, Gansu
GansuPMCH Recruiting
Lanzhou, Gansu, China, 730050
Contact: Yanxia Wang, Dr.    13893210796    1091771450@qq.com   
Sponsors and Collaborators
Gansu Provincial Maternal and Child Health Care Hospital
Investigators
Layout table for investigator information
Principal Investigator: Cheng Wang Gansu Provincial Maternal and Child Health Care Hospital
  Study Documents (Full-Text)

Documents provided by Gansu Provincial Maternal and Child Health Care Hospital:
Study Protocol  [PDF] April 20, 2023

Layout table for additonal information
Responsible Party: Gansu Provincial Maternal and Child Health Care Hospital
ClinicalTrials.gov Identifier: NCT06021691    
Other Study ID Numbers: NCRCCHD-2022-GP-17
First Posted: September 1, 2023    Key Record Dates
Last Update Posted: September 1, 2023
Last Verified: August 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Gansu Provincial Maternal and Child Health Care Hospital:
Child cognitive impairment
Intrauterine high-glucose environment
Acquired nurture environment
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes, Gestational
Pregnancy in Diabetics
Cognitive Dysfunction
Cognition Disorders
Neurocognitive Disorders
Mental Disorders
Pregnancy Complications
Female Urogenital Diseases and Pregnancy Complications
Urogenital Diseases
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases